CCR5 and influenza: Editing of CCR5 does not fit the first requirement as those homozygous for the CCR5-Δ32 mutation have unexpected negative effects such as earlier clinical manifestations for West Nile infection [23], four-fold likelihood of mortality from influenza infections [24], and disadvantageous osteoclast function [25].